Use of antipsychotics among older residents in VA nursing homes

Medical Care

Volumn 50, Issue 11, 2012, Pages 954-960

  Gellad, Walid F ^a,b,c   Aspinall, Sherrie L ^a,b,d   Handler, Steven M ^a,b,e   Stone, Roslyn A ^a,b   Castle, Nicholas ^b   Semla, Todd P ^f,g   Good, Chester B ^a,b,d   Fine, Michael J ^a,b   Dysken, Maurice ^h   Hanlon, Joseph T ^a,b,e,h  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c RAND CORPORATION   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

antipsychotics; nursing homes; pharmacoepidemiology; Veterans

Indexed keywords

NEUROLEPTIC AGENT;

AGED; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOSIS;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DEMENTIA; DRUG UTILIZATION; FEMALE; HEALTH STATUS; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; POLYPHARMACY; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84867712543     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31825fb21d     Document Type: Article

References (49)

1. Kales HC, Zivin K, Kim HM, et al. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry. 2011;68:190-197.
2. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuro-psychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293:596-608. (Pubitemid 40171242)
3. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280-1285. (Pubitemid 40989593)
4. Castle NG, Hanlon JT, Handler SM. Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. Am J Geriatr Pharmacother. 2009;7:143-150.
5. Chen Y, Briesacher BA, Field TS, et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170:89-95.
6. Kamble P, Chen H, Sherer J, et al. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother. 2008;6:187-197.
7. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167:676-683. (Pubitemid 46598460)
8. Stevenson DG, Decker SL, Dwyer LL, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18:1078-1092.
9. Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010; 58:880-888.
10. Department of Health and Human Services Office of the Inspector General. Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents. May 2011. Available at: http://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf. Accessed May 10, 2011.
11. O'Neil ME, Freeman M, Christensen V, et al. Non-pharmacological Interventions for Behavioral Symptoms of Dementia: A Systematic Review of the Evidence. VA-ESP Project #05-225. Washington, D.C.: Department of Veterans Affairs; 2011.
12. Lee PE, Gill SS, Freedman M, et al. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ. 2004;329:75.
13. Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306:1359-1369.
14. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355:1525-1538. (Pubitemid 44547805)
15. Rossom RC, Rector TS, Lederle FA, et al. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc. 2010;58:1027-1034.
16. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934-1943. (Pubitemid 41464695)
17. Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med. 2005;165:1882-1888. (Pubitemid 41352083)
18. Lee PE, Sykora K, Gill SS, et al. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults. J Am Geriatr Soc. 2005;53:1374-1379. (Pubitemid 41602483)
19. Avorn J. Medication use and the elderly: current status and opportunities. Health Aff (Millwood). 1995;14:276-286.
20. Avorn J, Dreyer P, Connelly K, et al. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study. N Engl J Med. 1989;320:227-232. (Pubitemid 19034149)
21. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med. 1995;123:195-204.
22. Ray WA, Blazer DG 2nd, Schaffner W, et al. Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit. Am J Public Health. 1987;77:1448-1450. (Pubitemid 18011594)
23. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-235.
24. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health. 1980;70:485-491. (Pubitemid 10098089)
25. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system. Psychiatr Serv. 2009;60:1175-1181.
26. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2): B10-B21. (Pubitemid 38569259)
27. Office of the Assistant Deputy Under Secretary for Health for Policy and Planning. VHA Enrollment, Patients and Expenditures. Washington, DC: U.S. Department of Veterans Affairs. 2008.
28. Government Accountability Office (GAO). VA Long-Term Care: Trends and Planning Challenges in Providing Nursing Home Care to Veterans. January 2006. Available at: http://www.gao.gov/new.items/d06333t.pdf. Accessed May 1, 2011.
29. Mor V. A comprehensive clinical assessment tool to inform policy and practice: applications of the minimum data set. Med Care. 2004; 42(suppl 4):III50-III59.
30. Hanlon JT, Wang X, Good CB, et al. Racial differences in medication use among older, long-stay Veterans Affairs nursing home care unit patients. Consult Pharm. 2009;24:439-446.
31. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
32. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
33. McConnell ES, Pieper CF, Sloane RJ, et al. Effects of cognitive performance on change in physical function in long-stay nursing home residents. J Gerontol A Biol Sci Med Sci. 2002;57:M778-M784. (Pubitemid 35470953)
34. Jordan N, Lee TA, Valenstein M, et al. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med. 2007;22:1447-1452. (Pubitemid 47476703)
35. Plomondon ME, Ho PM, Wang L, et al. Severe mental illness and mortality of hospitalized ACS patients in the VHA. BMC Health Serv Res. 2007;7:146.
36. Pugh MJ, Fincke BG, Bierman AS, et al. Potentially inappropriate prescribing in elderly veterans: are we using the wrong drug, wrong dose, or wrong duration? J Am Geriatr Soc. 2005;53:1282-1289. (Pubitemid 41602472)
37. Centers for Medicare and Medicaid Services (CMS). State Operations Manual. Guidance to Surveyors for Long Term Care Facilities. December 15, 2006. Available at: http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/ downloads/som107ap-pp-guidelines- ltcf.pdf. Accessed May 1, 2011.
38. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060. (Pubitemid 19026037)
39. French DD, Campbell RR, Spehar AM, et al. Drug costs and use in VHA nursing homes: a national overview of long-stay residents. J Am Med Dir Assoc. 2007;8:515-518. (Pubitemid 47532932)
40. Martin CM, McSpadden CS. Changes in the state operations manual: implications for consultant pharmacy practice. Consult Pharm. 2006; 21:948-961. (Pubitemid 44956801)
41. Bass E, Putney K, Alvear M. Economic aspects of dementia special care units in Veterans Affairs nursing homes. J Am Med Dir Assoc. 2005;6:276-280.
42. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9:430-434. (Pubitemid 46979143)
43. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
44. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327:168-173.
45. Marcum ZA, Handler SM, Wright R, et al. Interventions to improve suboptimal prescribing in nursing homes: a narrative review. Am J Geriatr Pharmacother. 2010;8:183-200.
46. Ray WA, Taylor JA, Meador KG, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med. 1993;153:713-721. (Pubitemid 23094850)
47. Karlin BE, Teri L, McGee JS, et al. STAR-VA: Manual for VA Community Living Center Mental Health Providers. Washington, DC: U.S. Department of Veterans Affairs; 2011.
48. Teri L, Huda P, Gibbons L, et al. STAR: a dementia-specific training program for staff in assisted living residences. Gerontologist. 2005; 45:686-693. (Pubitemid 41407535)
49. Papakostas GI, Shelton RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. J Clin Psychiatry. 2007;68:826-831. (Pubitemid 47015480)